Frontiers in Pharmacology (May 2023)

Corrigendum: BI 1015550 is a PDE4B inhibitor and a clinical drug candidate for the oral treatment of idiopathic pulmonary fibrosis

  • Franziska Elena Herrmann,
  • Christian Hesslinger,
  • Lutz Wollin,
  • Peter Nickolaus

DOI
https://doi.org/10.3389/fphar.2023.1219760
Journal volume & issue
Vol. 14

Abstract

Read online

No abstracts available.

Keywords